← Back to guidelines
Anesthesiology29 papers

Drug induced central sleep apnea

Last edited: 4/15/2026

Overview

Drug-induced central sleep apnea (CSA) occurs when medications disrupt normal respiratory control mechanisms during sleep, leading to pauses in breathing without physical obstruction. This condition is often observed with certain sedatives and anesthetic agents 13.

Diagnosis

  • Clinical Presentation: Presence of apneic episodes during sleep without evidence of obstructive components.
  • Polysomnography: Essential for confirming central apneas, assessing sleep architecture, and evaluating respiratory patterns 3.
  • Drug History: Review of current medications, particularly sedatives and anesthetics, is crucial 13.
  • Management

  • Drug Adjustment: Reduce or discontinue offending agents such as midazolam 3.
  • Alternative Sedatives: Consider alternatives like dexmedetomidine, which may have different respiratory effects 1.
  • Supportive Measures: Use of supplemental oxygen and monitoring for desaturation 3.
  • Flumazenil: For midazolam-induced effects, flumazenil can antagonize sedation but may not fully restore respiratory parameters 3.
  • Special Populations

  • Sex Differences: Males may exhibit more pronounced respiratory disturbances (e.g., increased rib cage motion, snoring) with midazolam compared to females 3.
  • Dosage Sensitivity: Higher doses of midazolam can exacerbate central apnea and sedation more significantly in females 3.
  • Key Recommendations

  • Monitor Respiratory Patterns: Regularly assess respiratory patterns, especially in patients on sedatives like midazolam, to detect early signs of central apnea (Evidence: Moderate 3).
  • Consider Sex-Specific Effects: Account for sex differences in response to sedatives, particularly midazolam, when managing respiratory complications (Evidence: Moderate 3).
  • Utilize Flumazenil for Reversal: Administer flumazenil cautiously to reverse midazolam-induced sedation, though it may not fully restore respiratory function (Evidence: Weak 3).
  • References

    1 Chen L, Zhang J, He W, Liu W. Comparative Effects of Dexmedetomidine and Midazolam on Dreaming of Patients Undergoing Flexible Bronchoscopy During General Anesthesia. Medical science monitor : international medical journal of experimental and clinical research 2021. link 2 Escalante GC, Balko JA, Chinnadurai SK. Comparison of the Sedative Effects of Alfaxalone and Butorphanol-Midazolam Administered Intramuscularly in Budgerigars (. Journal of avian medicine and surgery 2018. link 3 Masuda A, Haji A, Wakasugi M, Shibuya N, Shakunaga K, Ito Y. Differences in midazolam-induced breathing patterns in healthy volunteers. Acta anaesthesiologica Scandinavica 1995. link

    Original source

    1. [1]
      Comparative Effects of Dexmedetomidine and Midazolam on Dreaming of Patients Undergoing Flexible Bronchoscopy During General Anesthesia.Chen L, Zhang J, He W, Liu W Medical science monitor : international medical journal of experimental and clinical research (2021)
    2. [2]
      Comparison of the Sedative Effects of Alfaxalone and Butorphanol-Midazolam Administered Intramuscularly in Budgerigars (Escalante GC, Balko JA, Chinnadurai SK Journal of avian medicine and surgery (2018)
    3. [3]
      Differences in midazolam-induced breathing patterns in healthy volunteers.Masuda A, Haji A, Wakasugi M, Shibuya N, Shakunaga K, Ito Y Acta anaesthesiologica Scandinavica (1995)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG